1.
2.
3.
Nature
; 629(8013): 733-734, 2024 May.
Article
in English
| MEDLINE
| ID: mdl-38750205
4.
5.
6.
Nat Rev Drug Discov
; 23(5): 329, 2024 May.
Article
in English
| MEDLINE
| ID: mdl-38605116
7.
Nat Rev Drug Discov
; 23(5): 329, 2024 May.
Article
in English
| MEDLINE
| ID: mdl-38605117
8.
Nat Rev Drug Discov
; 23(5): 332-333, 2024 May.
Article
in English
| MEDLINE
| ID: mdl-38632392
9.
Nat Rev Drug Discov
; 23(5): 323-326, 2024 May.
Article
in English
| MEDLINE
| ID: mdl-38637628
10.
Nat Rev Drug Discov
; 23(4): 239, 2024 Apr.
Article
in English
| MEDLINE
| ID: mdl-38459351
11.
12.
Nat Rev Drug Discov
; 23(4): 244-245, 2024 Apr.
Article
in English
| MEDLINE
| ID: mdl-38429526
13.
Nat Rev Drug Discov
; 23(5): 328, 2024 May.
Article
in English
| MEDLINE
| ID: mdl-38548889
14.
15.
Nat Rev Drug Discov
; 23(3): 163, 2024 03.
Article
in English
| MEDLINE
| ID: mdl-38347157
16.
17.
Nat Rev Drug Discov
; 23(3): 159-161, 2024 03.
Article
in English
| MEDLINE
| ID: mdl-38374252
18.
Nat Rev Drug Discov
; 23(4): 238, 2024 Apr.
Article
in English
| MEDLINE
| ID: mdl-38374249
Subject(s)
Lymphocytes, Tumor-Infiltrating , Neoplasms , Humans , Immunotherapy, Adoptive , Interleukin-2 , Neoplasms/drug therapy
19.
20.